IFS Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$51.9K Hold
1,820
– – 0.02% 190
2026
Q2
$43.8K Hold
1,820
– – 0.02% 62
2026
Q1
$51.1K Hold
1,820
– – 0.03% 52
2025
Q4
$45.3K Hold
1,820
– – 0.02% 51
2025
Q3
$46.4K Hold
1,820
– – 0.03% 48
2025
Q2
$44.1K Sell
1,820
-2,166
-54% -$50.5K 0.03% 42
2025
Q1
$101K Buy
3,986
+293
+8% +$7.67K 0.08% 25
2024
Q4
$98K Buy
3,693
+3,277
+788% +$88.9K 0.08% 23
2024
Q3
$12K Hold
416
– – 0.01% 60
2024
Q2
$11.6K Hold
416
– – 0.01% 58
2024
Q1
$11.5K Hold
416
– – 0.01% 58
2023
Q4
$12K Hold
416
– – 0.01% 51
2023
Q3
$13.8K Hold
416
– – 0.03% 46
2023
Q2
$15.3K Hold
416
– – 0.04% 40
2023
Q1
$17K Hold
416
– – 0.07% 35
2022
Q4
$21.3K Hold
416
– – 0.04% 33
2022
Q3
$18K Hold
416
– – 0.03% 33
2022
Q2
$21K Hold
416
– – 0.06% 29
2022
Q1
$21K Hold
416
– – 0.02% 37
2021
Q4
$24K Buy
+416
New +$20.6K 0.02% 46
2021
Q1
– Sell
-916
Closed -$33K – 113
2020
Q4
$33K Buy
+916
New +$33.6K 0.03% 57

Other funds holding PFE

IFS Advisors's PFE Position: Q3 2026 in Review

IFS Advisors held its Pfizer (PFE) position steady in Q3 2026 at 1,820 shares worth $51.9K. The position accounts for 0.02% of the portfolio, ranked #190.

IFS Advisors first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. The position peaked at $101K in Q1 2025. 718 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • IFS Advisors held 1,820 shares of Pfizer worth $51.9K as of Q3 2026.
  • IFS Advisors left its Pfizer share count unchanged in Q3 2026.
  • Pfizer made up 0.02% of IFS Advisors's portfolio in Q3 2026, its #190 holding.
  • IFS Advisors first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
  • IFS Advisors's Pfizer position peaked at $101K in Q1 2025.
  • 718 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on IFS Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.